Literature DB >> 112540

The otolaryngologic presentation of amyotrophic lateral sclerosis.

R J Carpenter, T J McDonald, F M Howard.   

Abstract

Amyotrophic lateral sclerosis is a progressive dengenerative neuromuscular disease of insidious onset. It involves upper and lower motor neurons and causes both spastic and atrophic muscular symptoms. More than one fourth of patients have complaints relating to the head and neck (bulbar palsy); thus, the otolaryngologist may be the first physician to see them. Predominant symptoms are slurred speech, hoarseness, dysphagia, and dyspnea. Muscular weakness, atrophy, and fasciculation are noted on examination. The course is relentless, and only 20% of patients survive five years after diagnosis.

Entities:  

Mesh:

Year:  1978        PMID: 112540     DOI: 10.1177/019459987808600319

Source DB:  PubMed          Journal:  Otolaryngology        ISSN: 0161-6439


  13 in total

1.  The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States.

Authors:  Emily K Plowman; Lauren C Tabor; James Wymer; Gary Pattee
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-04-20       Impact factor: 4.092

Review 2.  Epidemiology and dysphagia.

Authors:  K V Kuhlemeier
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

3.  Impact of expiratory strength training in amyotrophic lateral sclerosis.

Authors:  Emily K Plowman; Stephanie A Watts; Lauren Tabor; Raele Robison; Joy Gaziano; Amanda S Domer; Joel Richter; Tuan Vu; Clifton Gooch
Journal:  Muscle Nerve       Date:  2016-03-03       Impact factor: 3.217

4.  Speech Movement Measures as Markers of Bulbar Disease in Amyotrophic Lateral Sclerosis.

Authors:  Sanjana Shellikeri; Jordan R Green; Madhura Kulkarni; Panying Rong; Rosemary Martino; Lorne Zinman; Yana Yunusova
Journal:  J Speech Lang Hear Res       Date:  2016-10-01       Impact factor: 2.297

5.  Histological and ultrastructural findings in the vocal muscles of patients suffering from muscular dystrophies.

Authors:  L Manolides; S Baloyannis
Journal:  Arch Otorhinolaryngol       Date:  1981

6.  Shifting Tides Toward a Proactive Patient-Centered Approach in Dysphagia Management of Neurodegenerative Disease.

Authors:  Nicole M Rogus-Pulia; Emily K Plowman
Journal:  Am J Speech Lang Pathol       Date:  2020-07-10       Impact factor: 2.408

7.  Defining Swallowing-Related Quality of Life Profiles in Individuals with Amyotrophic Lateral Sclerosis.

Authors:  Lauren Tabor; Joy Gaziano; Stephanie Watts; Raele Robison; Emily K Plowman
Journal:  Dysphagia       Date:  2016-02-02       Impact factor: 3.438

8.  Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Monika Gołąb-Janowska; Anna Sobuś; Agnieszka Wełnicka; Agnieszka Meller; Karolina Machowska-Sempruch; Alicja Zawiślak; Karolina Łuczkowska; Sławomir Milczarek; Bogumiła Osękowska; Edyta Paczkowska; Iwona Rotter; Przemysław Nowacki; Bogusław Machaliński
Journal:  Stem Cells Int       Date:  2019-06-02       Impact factor: 5.443

9.  Neuropathology of Speech Network Distinguishes Bulbar From Nonbulbar Amyotrophic Lateral Sclerosis.

Authors:  Sanjana Shellikeri; Julia Keith; Sandra E Black; Lorne Zinman; Yana Yunusova
Journal:  J Neuropathol Exp Neurol       Date:  2020-03-01       Impact factor: 3.685

10.  Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems.

Authors:  Panying Rong; Yana Yunusova; Jun Wang; Lorne Zinman; Gary L Pattee; James D Berry; Bridget Perry; Jordan R Green
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.